Remote Therapeutic Monitoring
ADVI worked with the client and the AMA’s Digital Medicine Payment Advisory Committee to develop new CPT codes for remote therapeutic monitoring.
ADVI worked with the client and the AMA’s Digital Medicine Payment Advisory Committee to develop new CPT codes for remote therapeutic monitoring. The new codes were accepted by the CPT Editorial Panel and include the collection and physician review of patient reported outcomes associated with exposure to the therapy in addition to objective clinical data. ADVI also worked with the specialties and the AMA/RUC process to submit cost data on specific devices for inclusion in practice expense relative values.
CEO insights
Related articles
Real analysis from people who’ve been there
Cardiovascular Technologies
Reviewed primary clinical study literature and, based on published Medicare precedents and processes, produced mock National Coverage Determinations on several invasive cardiovascular technologies, applying typical CMS standards and formats.
Lumbar Spine Stenosis Device
ADVI worked with the client and CMS to reverse a negative draft NCD and obtained a final NCD with CED that required a randomized clinical study.
Non-Opioid Device Pain Relief Product
Assessed the positioning of a client's non-opioid pain relief device versus competitive products, including drugs and other devices used to treat pain.
AI Device for Osteoporosis Assessment
ADVI helped a client obtain a new Category I CPT code for the trabecular bone score AI software device.
Osseochondral Knee Implant
ADVI analyzed the reimbursement environment for a novel osseochondral implant under development to determine whether existing codes and payment would be sufficient for the new device.
Wound Product
Repositioned a struggling wound care device away from dressings and obtained a new CPT code allowing a physician or qualified healthcare professional to dispense the device as part of a professional service.
Reach out
Own your edge
We don’t just guide the market. We shape it. Map your market access moves with #ADVIIntelligence. Proven advantage. Unmatched partnership.